focus -WSS

focus

author：leisure time 2025-09-28 14:18:15 - browse：81387

Adobe

Akili Interactive, which in 2020 made waves by receiving Food and Drug Administration clearance for its video game that improves symptoms of ADHD in children, on Wednesday announced it would reorient its business around selling its products directly to users over the counter, rather than by prescription.

In connection with the move away from prescription sales, Akili will reduce its workforce by 40%, which the company projects will extend its runway into the second half of 2025. The Boston-based company will continue offering its pediatric treatment, EndeavorRx, by prescription until it can convert it to over-the-counter labeling — it plans to submit data to FDA in 2024.

Akili went public last year and though its prescription sales were slowly increasing, the company’s costs far outstripped its revenues. In its second-quarter results reported in August, Akili said it earned just $114,000 on $15.3 million in expenses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： AI gets buy

hotspot

focus

WSS

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Johnson & Johnson sued for allegedly overpaying for workers' drugs

A single Democrat is willing to weaken Medicare negotiation power

Medicare Advantage plans can’t deny care with AI, CMS warns

Pediatric cancer treatments threatened by a new FDA policy

Johnson & Johnson sued for allegedly overpaying for workers' drugs

leisure time

focus

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Medical leaders decry Supreme Court decision on affirmative action

Johnson & Johnson sued for allegedly overpaying for workers' drugs

What does generative AI mean for health care? We asked experts

Medicare Advantage plans can’t deny care with AI, CMS warns

Anesthesiologist group: stop taking Ozempic before surgery

Fetal surgery at risk from Dobbs and new abortion restrictions

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

UnitedHealth’s Optum accused of antitrust violations in California

explore

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

What to do when lifesaving products contribute to climate change

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Problems with a popular proposal to regulate AI in health care

What’s missing from the debate over nursing home staff minimums

A single Democrat is willing to weaken Medicare negotiation power

focus

hotspot

focus

focus